| T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study P Deepak, H Sifuentes, M Sherid, D Stobaugh, Y Sadozai, ED Ehrenpreis Official journal of the American College of Gastroenterology| ACG 108 (1 …, 2013 | 250 | 2013 |
| Neurological events with tumour necrosis factor alpha inhibitors reported to the Food and Drug Administration Adverse Event Reporting System P Deepak, DJ Stobaugh, M Sherid, H Sifuentes, ED Ehrenpreis Alimentary pharmacology & therapeutics 38 (4), 388-396, 2013 | 106 | 2013 |
| Wheel running can accelerate or delay extinction of conditioned place preference for cocaine in male C57BL/6J mice, depending on timing of wheel access ML Mustroph, DJ Stobaugh, DS Miller, EK DeYoung, JS Rhodes European Journal of Neuroscience 34 (7), 1161-1169, 2011 | 81 | 2011 |
| Infectious complications of TNF-α inhibitor monotherapy versus combination therapy with immunomodulators in inflammatory bowel disease: analysis of the Food and Drug … P Deepak, DJ Stobaugh, ED Ehrenpreis Journal of Gastrointestinal & Liver Diseases 22 (3), 2013 | 73 | 2013 |
| Melanoma and non-melanoma skin cancer in inflammatory bowel disease patients following tumor necrosis factor-α inhibitor monotherapy and in combination with thiopurines … MR McKenna, DJ Stobaugh, P Deepak Journal of Gastrointestinal & Liver Diseases 23 (3), 2014 | 66 | 2014 |
| Maternal and foetal adverse events with tumour necrosis factor‐alpha inhibitors in inflammatory bowel disease P Deepak, DJ Stobaugh Alimentary pharmacology & therapeutics 40 (9), 1035-1043, 2014 | 47 | 2014 |
| Increased risk of osteoporosis-related fractures in patients with irritable bowel syndrome DJ Stobaugh, P Deepak, ED Ehrenpreis Osteoporosis International 24, 1169-1175, 2013 | 44 | 2013 |
| Blockade of arginine vasotocin signaling reduces aggressive behavior and c-Fos expression in the preoptic area and periventricular nucleus of the posterior tuberculum in male … C Yaeger, AM Ros, V Cross, RS DeAngelis, DJ Stobaugh, JS Rhodes Neuroscience 267, 205-218, 2014 | 43 | 2014 |
| Hospitalizations for vaccine preventable pneumonias in patients with inflammatory bowel disease: a 6-year analysis of the Nationwide Inpatient Sample DJ Stobaugh, P Deepak, ED Ehrenpreis Clinical and Experimental Gastroenterology, 43-49, 2013 | 40 | 2013 |
| Alleged isotretinoin-associated inflammatory bowel disease: disproportionate reporting by attorneys to the Food and Drug Administration Adverse Event Reporting System DJ Stobaugh, P Deepak, ED Ehrenpreis Journal of the American Academy of Dermatology 69 (3), 393-398, 2013 | 29 | 2013 |
| Effect of Tumor Necrosis Factor–α Inhibitors on Drug-Induced Pancreatitis in Inflammatory Bowel Disease DJ Stobaugh, P Deepak Annals of Pharmacotherapy 48 (10), 1282-1287, 2014 | 21 | 2014 |
| Determinants of palliative care utilization among patients hospitalized with metastatic gastrointestinal malignancies PN Okafor, DJ Stobaugh, AK Nnadi, JA Talwalkar American Journal of Hospice and Palliative Medicine® 34 (3), 269-274, 2017 | 20 | 2017 |
| Assessing the likelihood of new-onset inflammatory bowel disease following tumor necrosis factor-alpha inhibitor therapy for rheumatoid arthritis and juvenile rheumatoid arthritis A Krishnan, DJ Stobaugh, P Deepak Rheumatology international 35, 661-668, 2015 | 20 | 2015 |
| Ischaemic colitis in rheumatoid arthritis patients receiving tumour necrosis factor-α inhibitors: an analysis of reports to the US FDA adverse event reporting system A Salk, DJ Stobaugh, P Deepak, ED Ehrenpreis Drug safety 36, 329-334, 2013 | 19 | 2013 |
| Ischemic colitis with type I interferons used in the treatment of hepatitis C and multiple sclerosis: an evaluation from the food and drug administration adverse event … A Salk, DJ Stobaugh, P Deepak, ED Ehrenpreis Annals of Pharmacotherapy 47 (4), 537-542, 2013 | 18 | 2013 |
| African Americans have better outcomes for five common gastrointestinal diagnoses in hospitals with more racially diverse patients PN Okafor, DJ Stobaugh, M Van Ryn, JA Talwalkar Official journal of the American College of Gastroenterology| ACG 111 (5 …, 2016 | 12 | 2016 |
| Socioeconomic inequalities in the utilization of colorectal stents for the treatment of malignant bowel obstruction PN Okafor, DJ Stobaugh, LM Wong Kee Song, PJ Limburg, JA Talwalkar Digestive diseases and sciences 61, 1669-1676, 2016 | 7 | 2016 |
| Simulated comparison of topical and oral formulations of 5-aminosalicylate for the treatment of ulcerative colitis DJ Stobaugh, P Deepak, M Thorpe, B Hannon, ED Ehrenpreis Inflammatory bowel diseases 19 (2), 301-308, 2013 | 6 | 2013 |
| An Analysis of Hospital Charges and Length of Stay in Patients with Eosinophilic Esophagitis Admitted for Foreign Body in the Esophagus: 33 D Stobaugh, P Deepak, E Ehrenpreis Official journal of the American College of Gastroenterology| ACG 108, S12-S13, 2013 | 4 | 2013 |
| Mo1198 Risk of Pancreatitis With Tumor Necrosis Factor-Alpha Inhibitors Among Inflammatory Bowel Disease Patients: An Analysis of the Food and Drug Administration Adverse Event … DJ Stobaugh, S Samo, P Deepak, ED Ehrenpreis Gastroenterology 5 (146), S-583-S-584, 2014 | 3 | 2014 |
Parakkal Deepak M.B.B.S., M.S., FACGAssociate Professor of Medicine, Div. of Gastroenterology, Washington University School of Medicine在 wustl.edu 的电子邮件经过验证
